Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
76,383.55
(
-0.40%
)
News Focus
News Focus
Post# of 108195
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mpreorder

Send PM Follow Ignore
Followers 2
Posts 333
Boards Moderated 0
Alias Born 07/19/2016

mpreorder

Re: pitching51 post# 43665

Tuesday, 11/21/2017 8:06:42 AM

Tuesday, November 21, 2017 8:06:42 AM

Post# of 108195
The volume change is totally insignificant, the dose did not change.
What is significant is that the trial is no longer recruiting. There were only supposed to be 30 patients dosed, so it seems they are on track. They are in a data collection period now, getting results from those already doses. This phase will complete by August 2018 and we can expect results in 2019.

Again, nothing unexpected.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today